MMP7 inhibitor (SelectImmune Pharma)

N/A

Report date: 2025/03/20 15:56:58
NME

Base Information

Drug NameMMP7 inhibitor (SelectImmune Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrilysin inhibitors
TargetsMatrilysin
Therapy Area/IndicationsCystitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEuropeAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSelectImmune Pharma AB
China Registration ClassN/A

Develop Information

Active CompaniesHamlet BioPharma AB
Inactive CompaniesSelectImmune Pharma AB
Active IndicationsCystitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A